Strategic collaboration in health research and innovation between EU and China
The objective of this action is to support networking between European and Chinese policy makers, programme owners and funders, with the following goals:
- To develop a sustainable platform between EU and China that will facilitate a constant dialogue on addressing common health R&I challenges.
- To identify health challenges, whose solution may benefit from closer bi-lateral and/or multi-lateral cooperation between EU and China, to facilitate and develop collaborative research initiatives between EU and Chinese stakeholders.
The Commission considers that a proposal requesting an EU contribution between EUR 0.8 and 1 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
Compared to its size and increasing weight on the R&I international scene, China's participation and cooperation to the Horizon 2020 SC1 programmes is low. This is a lost opportunity because most of the major health challenges are global, and cooperation with China on specific strategic health challenges can contribute to provide more evidence-based solutions and to avoid duplication.
- Increased bi-lateral and multi-lateral cooperation on health research strategic items between EU and China.
- Higher participation of Chinese researchers in SC1 and future EU health research programmes, but also of European researchers in Chinese health research programmes.